Please ensure Javascript is enabled for purposes of website accessibility

8 Stocks on Wall Street's Buy List

By Jennifer Schonberger - Updated Apr 5, 2017 at 8:03PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What are the analysts saying? Should you listen?

We all want the best in life -- whether it's the best clothes, the best cars, the best houses, or ... the best stocks.

One way to find the best stocks is to look for companies that multiple analysts -- not just one -- have picked to outperform. It's the analysts' job to rate companies based on their fundamentals, outlook, and valuation, so if several analysts have a buy rating on a particular stock, that might just mean it's a winner.

Take offshore oil and gas driller Transocean (NYSE:RIG), which has an "outperform" rating from 28 analysts on the Street, or health-care juggernaut Johnson & Johnson (NYSE:JNJ), which has get a healthy 30 "outperform" votes. When the stocks' prices are knocked down -- as they are for these -- the time might just be ripe to add them to your portfolio.

Check under the hood of these analyst ratings, and you do indeed find strong companies trading at low multiples. Transocean warrants its favorable valuation -- it sells at a price-to-earnings multiple of 3.6 at around $54 per share, compared with 10 to 11 in April, when the stock sold in the $150-$160 range. The selloff in oil futures has caused the stock to get pummeled, but the company still maintains 90% of its backlog in investment-grade companies. What's more, the CEO noted in the company's third-quarter conference call that a soft labor market, in conjunction with collapsing commodity prices, could quell increases on the cost side of the business.

Johnson & Johnson, meanwhile, continues to post vigorous results despite the adverse effect that generic products are having on the pharmaceutical industry. The company is also making synergstic acquisitions for the long haul -- including its purchase of Mentor, a manufacturer of breast implants. That acquisition should allow its surgical-instrument unit, Ethicon, to augment its presence in aesthetic and reconstructive medicine. J&J sells for a P/E of 13, compared with a pricier 16-17 last August.

Analyst ratings can lead to finding strong investment candidates. So, wouldn't it be great to know which companies Wall Street favors the most? To find some of the Street's favorite companies, I used the screening tool at the "wisdom of crowds" club we call CAPS. I screened using the following criteria:

  • Stocks with 10 or more "outperform" ratings from Wall Street analysts.
  • Stocks with 1,000 or more "outperform" ratings from members The Motley Fool's CAPS community.
  • Stocks with CAPS ratings of five stars, the highest possible. During the first 20 months for which we have data, five-star companies have outperformed the market, with average annualized gains of 12%.
  • Stocks with market caps of $5 billion or greater.

Here are some of the companies that showed up:

Company

No. of Wall Street Analysts With "Outperform" Ratings

Outperform Picks in CAPS Community

Market Cap (in Billions)

3M (NYSE:MMM)

22

3433

$38.9

Activision Blizzard (NASDAQ:ATVI)

28

2915

$13.4

Applied Materials (NASDAQ:AMAT)

25

1455

$13.8

Chesapeake Energy

24

5978

$8.8

EMC (NYSE:EMC)

21

2853

$21.6

Johnson & Johnson

30

10125

$160.4

Transocean

28

4717

$17.1

XTO Energy (NYSE:XTO)

22

2039

$20.5

Source: Motley Fool CAPS.

Keep in mind, though, that while analysts understand equities well, you shouldn't purchase stocks based solely on their "buy" recommendations. Instead, make their calls an indicator for further research, to see whether a particular stock is right for your portfolio.

Start searching for Wall Street's favorite stocks at Motley Fool CAPS today! Let the collective wisdom of our 120,000-member-strong (and growing!) investment community help you make better investing decisions.

For Related Foolishness:

Fool contributor Jennifer Schonberger owns shares in Johnson & Johnson but of no other companies mentioned in this article. 3M and Chesapeake Energy are Motley Fool Inside Value recommendations. Activision Blizzard is recommended in Stock Advisor. J&J is an Income Investor pick. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Transocean Ltd. Stock Quote
Transocean Ltd.
RIG
$3.58 (1.13%) $0.04
Johnson & Johnson Stock Quote
Johnson & Johnson
JNJ
$167.14 (-2.07%) $-3.53
Dell EMC Stock Quote
Dell EMC
EMC
3M Company Stock Quote
3M Company
MMM
$149.66 (0.19%) $0.28
Applied Materials, Inc. Stock Quote
Applied Materials, Inc.
AMAT
$105.53 (0.46%) $0.48
Activision Blizzard, Inc. Stock Quote
Activision Blizzard, Inc.
ATVI
$80.51 (-0.49%) $0.40
XTO Energy Inc. Stock Quote
XTO Energy Inc.
XTO.DL

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
390%
 
S&P 500 Returns
125%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/12/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.